Perk inhibiting imidazolopyrazine compounds
US12331054B2 · kind B2 · utility
0Cited by
1References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 28, 2020 |
| Grant date | Jun 17, 2025 |
| Priority date | — |
| Expiry date | Oct 2, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are compounds, compositions, and methods useful for inhibiting PERK and for treating related conditions, diseases, and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.